Obstructive sleep apnea is associated with liver disease: A population-based cohort study

Sleep Medicine

Volumn 16, Issue 8, 2015, Pages 955-960

  Chou, Tzu Chieh ^a   Liang, Wen Miin ^a   Wang, Chang Bi ^a   Wu, Trong Neng ^a,b   Hang, Liang Wen ^a,c,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Department of Nursing College of Medicine and Nursing Hunguang University   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

Cirrhosis; Hepatitis B; Hepatitis C; Liver disease; Non alcoholic fatty liver disease; Obstructive sleep apnea

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INCOME; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; NONALCOHOLIC FATTY LIVER; PATIENT SELECTION; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; TAIWAN; URBANIZATION; CASE CONTROL STUDY; COMPLICATION; LIVER DISEASES; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK FACTOR;

ADULT; CASE-CONTROL STUDIES; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; INCIDENCE; LIVER CIRRHOSIS; LIVER DISEASES; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84942983751     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2015.02.542     Document Type: Article

References (47)

1. Amarapurkar D, Kamani P, Patel N, et al. Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol 2007;6(3):161-3.
2. Perz JF, Armstrong GL, Farrington LA, et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006;45(4):529-38.
3. Yan H, Luo JY, Zhou XY. Epidemiological analysis of alcoholic and nonalcoholic fatty liver in Shanxi and Gansu province. Weichang Bingxue he Ganbing Xue Zazhi 2007;16:347-50.
4. Chen CH, Huang MH, Yang JC, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol 2006;40(8):745-52.
5. Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000;132(2):112-17.
6. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004;114(2):147-52.
7. Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006;40(Suppl. 1):S5-10.
8. McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol 2006;40(Suppl. 1):S17-29.
9. Clark JM, Diehl AM. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 2003;289(22):3000-4.
10. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37(4):917-23.
11. Li WC, Lee YY, Chen IC, et al. Association between the hepatitis B and C viruses and metabolic diseases in patients stratified by age. Liver Int 2013;33(8):1194-202.
12. Wang CS, Chang TT, Yao WJ, et al. Comparison of hepatitis B virus and hepatitis C virus prevalence and risk factors in a community-based study. Am J Trop Med Hyg 2002;66(4):389-93.
13. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123(1):134-40.
14. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121(1):91-100.
15. Kohler M, Stradling JR. Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 2010;7(12):677-85.
16. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003;37(5):1202-19.
17. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 2000;21(3):49-98.
18. Punjabi NM, Caffo BS, Goodwin JL, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009;6(8):e1000132.
19. Cartwright RD, Knight S. Silent partners: the wives of sleep apneic patients. Sleep 1987;10(3):244-8.
20. Blankfield RP, Hudgel DW, Tapolyai AA, et al. Bilateral leg edema, obesity, pulmonary hypertension, and obstructive sleep apnea. Arch Intern Med 2000;160(15):2357-62.
21. Sajkov D, Wang T, Saunders NA, et al. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2002;165(2):152-8.
22. Sun H, Shi J, Li M, et al. Impact of continuous positive airway pressure treatment on left ventricular ejection fraction in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials. PLoS ONE 2013;8(5):e62298.
23. Engleman HM, Kingshott RN, Martin SE, et al. Cognitive function in the sleep apnea/hypopnea syndrome (SAHS). Sleep 2000;23(Suppl. 4):S102-8.
24. George CF, Smiley A. Sleep apnea and automobile crashes. Sleep 1999;22(6):790-5.
25. Ulfberg J, Carter N, Edling C. Sleep-disordered breathing and occupational accidents. Scand J Work Environ Health 2000;26(3):237-42.
26. Musso G, Cassader M, Olivetti C, et al. Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis. Obes Rev 2013;14:417-31.
27. Jun J, Savransky V, Nanayakkara A, et al. Intermittent hypoxia has organ-specific effects on oxidative stress. Am J Physiol Regul Integr Comp Physiol 2008;295(4):R1274-81.
28. Lin TJ, Lin CL, Wang CS, et al. Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan. World J Gastroenterol 2005;11(25):3905-8.
29. Tatsumi K, Saibara T. Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis. Hepatol Res 2005;33(2):100-4.
30. Tanne F, Gagnadoux F, Chazouilleres O, et al. Chronic liver injury during obstructive sleep apnea. Hepatology 2005;41(6):1290-6.
31. Mishra P, Nugent C, Afendy A, et al. Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis. Liver Int 2008;28(8):1080-6.
32. Edmison J, McCullough AJ. Pathogenesis of non-alcoholic steatohepatitis: human data. Clin Liver Dis 2007;11(1):75-104, ix.
33. Singh H, Pollock R, Uhanova J, et al. Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease. Dig Dis Sci 2005;50(12):2338-43.
34. Turkay C, Ozol D, Kasapoglu B, et al. Influence of obstructive sleep apnea on fatty liver disease: role of chronic intermittent hypoxia. Respir Care 2012;57(2):244-9.
35. Pamidi S, Tasali E. Obstructive sleep apnea and type 2 diabetes: is there a link? Front Neurol 2012;3:126.
36. Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol 2009;106(5):1538-44.
37. Abdelmalek MF, Diehl AM. Nonalcoholic fatty liver disease as a complication of insulin resistance. Med Clin North Am 2007;91(6):1125-49.
38. Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2008;118(3):829-38.
39. Sockalingam S, Abbey SE, Alosaimi F, et al. A review of sleep disturbance in hepatitis C. J Clin Gastroenterol 2010;44(1):38-45.
40. Samarasinghe DA, Tapner M, Farrell GC. Role of oxidative stress in hypoxiareoxygenation injury to cultured rat hepatic sinusoidal endothelial cells. Hepatology 2000;31(1):160-5.
41. Nath B, Szabo G. Hypoxia and hypoxia inducible factors: diverse roles in liver diseases. Hepatology 2012;55(2):622-33.
42. Gomez-Gonzalez B, Dominguez-Salazar E, Hurtado-Alvarado G, et al. Role of sleep in the regulation of the immune system and the pituitary hormones. Ann N Y Acad Sci 2012;1261:97-106.
43. Lange T, Perras B, Fehm HL, et al. Sleep enhances the human antibody response to hepatitis A vaccination. Psychosom Med 2003;65(5):831-5.
44. Prather AA, Hall M, Fury JM, et al. Sleep and antibody response to hepatitis B vaccination. Sleep 2012;35(8):1063-9.
45. Deegan PC, McNicholas WT. Pathophysiology of obstructive sleep apnoea. Eur Respir J 1995;8(7):1161-78.
46. Arnardottir ES, Mackiewicz M, Gislason T, et al. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 2009;32(4):447-70.
47. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328(17):1230-5.